Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection

Virology. 1993 Mar;193(1):528-30. doi: 10.1006/viro.1993.1160.

Abstract

Human immunodeficiency virus type 2 (HIV-2) has been reported to be less pathogenic than HIV-1. We have investigated the capacity of sera from nine HIV-2-infected individuals to neutralize their own autologous virus. All nine HIV-2-infected individuals neutralized autologous virus with titers ranging between 20 and 320. In contrast, we have previously reported that most HIV-1-infected individuals lack such antibodies. The difference between HIV-1 and HIV-2 infection was statistically significant (P < 0.0002, Pearson test) and the difference in neutralizing antibody prevalence may explain the faster disease progression in HIV-1-infected individuals than in HIV-2-infected individuals.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • HIV Antibodies / blood*
  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • HIV-2 / immunology*
  • Humans
  • Neutralization Tests

Substances

  • HIV Antibodies